美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA210046"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
70121-1238-1 70121-1238 HUMAN PRESCRIPTION DRUG Cyclophosphamide Cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20180531 N/A ANDA ANDA210046 Amneal Pharmaceuticals LLC CYCLOPHOSPHAMIDE 500 mg/25mL 1 VIAL, SINGLE-DOSE in 1 CARTON (70121-1238-1) / 25 mL in 1 VIAL, SINGLE-DOSE
70121-1239-1 70121-1239 HUMAN PRESCRIPTION DRUG Cyclophosphamide Cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20180531 N/A ANDA ANDA210046 Amneal Pharmaceuticals LLC CYCLOPHOSPHAMIDE 1 g/50mL 1 VIAL, SINGLE-DOSE in 1 CARTON (70121-1239-1) / 50 mL in 1 VIAL, SINGLE-DOSE
70121-1240-1 70121-1240 HUMAN PRESCRIPTION DRUG Cyclophosphamide Cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20180531 N/A ANDA ANDA210046 Amneal Pharmaceuticals LLC CYCLOPHOSPHAMIDE 2 g/100mL 1 VIAL, SINGLE-DOSE in 1 CARTON (70121-1240-1) / 100 mL in 1 VIAL, SINGLE-DOSE
72603-104-01 72603-104 HUMAN PRESCRIPTION DRUG Cyclophosphamide Cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20190510 N/A ANDA ANDA210046 NorthStar RxLLC CYCLOPHOSPHAMIDE 500 mg/25mL 1 VIAL, SINGLE-DOSE in 1 CARTON (72603-104-01) / 25 mL in 1 VIAL, SINGLE-DOSE
72603-326-01 72603-326 HUMAN PRESCRIPTION DRUG Cyclophosphamide Cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20190510 N/A ANDA ANDA210046 NorthStar RxLLC CYCLOPHOSPHAMIDE 1 g/50mL 1 VIAL, SINGLE-DOSE in 1 CARTON (72603-326-01) / 50 mL in 1 VIAL, SINGLE-DOSE
72603-411-01 72603-411 HUMAN PRESCRIPTION DRUG Cyclophosphamide Cyclophosphamide INJECTION, POWDER, FOR SOLUTION INTRAVENOUS; ORAL 20190510 N/A ANDA ANDA210046 NorthStar RxLLC CYCLOPHOSPHAMIDE 2 g/100mL 1 VIAL, SINGLE-DOSE in 1 CARTON (72603-411-01) / 100 mL in 1 VIAL, SINGLE-DOSE
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase